Dupilumab (Dupixent) and tralokinumab (Adbry) are immunotherapy drugs approved to treat moderate to severe eczema. Other potential treatments are undergoing clinical trials. Immunotherapy is a treatment option for moderate or severe atopic dermatitis (eczema) that doesn’t respond to other treatments. This class of drugs uses your body’s immune system to alter reactions that contribute to […]
SINGAPORE – New treatments for skin conditions such as psoriasis, eczema, vitiligo and melasma were among the latest developments showcased at the 25th World Congress of Dermatology (WCD), the largest medical event ever held here, from last Monday to Saturday. Over the past decade, dermatology has been second only to cancer in terms of having […]
Follicular Eczema: Symptoms, Causes, Treatments Healthgrades Source link
With the development of new therapies, patients with atopic dermatitis (AD) will receive more effective treatment in the future, according to a recent study. AD is most often seen in children, leading to itchy, inflammatory skin. In many cases, childhood AD is linked with parental eczema, and is also the most common skin disease, with […]